HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Fragrance manufacturer improves 2003 financial outlook, with sales now expected to reach $182 mil. on growth of prestige fragrances and initial sales of Burberry Brit, firm says. Estimate is up from previous projection of $177 mil.-$179 mil. (1"The Rose Sheet" Oct. 13, 2003, In Brief). Net income is expected to be $13.4 mil. for the year, versus prior estimate of $12.7 mil.-$12.9 mil. Inter Parfums 2004 sales are projected to be about $206 mil., with net income of approximately $15 mil., assuming the dollar remains at current levels, company says...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel